Dr. Tina Garyantes is an experienced board director, innovative serial entrepreneur, and pharmaceutical executive.  She helps companies plan, execute and secure funding for the rapid development of novel drugs and technologies.  Tina applies her broad technical and business background to anticipating and solving complex problems from the bench to the negotiating table. She is currently working to extend the healthy, active life of cancer patients at Linnaeus Therapeutics. In previous roles at Merck and Sanofi among others, she has invented, developed, and out-licensed technologies such as the first commercial instrument for the fine structure of DNA, a well-less 1536 plate system, an automated cell culture system, and a non-addictive pain therapy.  Tina serves on several biotech and non-profit boards and is excited to have the opportunity to help develop future female STEM leaders.